Hypr-Seq: Single-Cell Quantification of Chosen Rnas Via Hybridization and Sequencing of DNA Probes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications
Stem Cell Rev and Rep DOI 10.1007/s12015-016-9662-8 Detailed Characterization of Human Induced Pluripotent Stem Cells Manufactured for Therapeutic Applications Behnam Ahmadian Baghbaderani 1 & Adhikarla Syama2 & Renuka Sivapatham3 & Ying Pei4 & Odity Mukherjee2 & Thomas Fellner1 & Xianmin Zeng3,4 & Mahendra S. Rao5,6 # The Author(s) 2016. This article is published with open access at Springerlink.com Abstract We have recently described manufacturing of hu- help determine which set of tests will be most useful in mon- man induced pluripotent stem cells (iPSC) master cell banks itoring the cells and establishing criteria for discarding a line. (MCB) generated by a clinically compliant process using cord blood as a starting material (Baghbaderani et al. in Stem Cell Keywords Induced pluripotent stem cells . Embryonic stem Reports, 5(4), 647–659, 2015). In this manuscript, we de- cells . Manufacturing . cGMP . Consent . Markers scribe the detailed characterization of the two iPSC clones generated using this process, including whole genome se- quencing (WGS), microarray, and comparative genomic hy- Introduction bridization (aCGH) single nucleotide polymorphism (SNP) analysis. We compare their profiles with a proposed calibra- Induced pluripotent stem cells (iPSCs) are akin to embryonic tion material and with a reporter subclone and lines made by a stem cells (ESC) [2] in their developmental potential, but dif- similar process from different donors. We believe that iPSCs fer from ESC in the starting cell used and the requirement of a are likely to be used to make multiple clinical products. We set of proteins to induce pluripotency [3]. Although function- further believe that the lines used as input material will be used ally identical, iPSCs may differ from ESC in subtle ways, at different sites and, given their immortal status, will be used including in their epigenetic profile, exposure to the environ- for many years or even decades. -
Tumour-Stroma Signalling in Cancer Cell Motility and Metastasis
Tumour-Stroma Signalling in Cancer Cell Motility and Metastasis by Valbona Luga A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy, Department of Molecular Genetics, University of Toronto © Copyright by Valbona Luga, 2013 Tumour-Stroma Signalling in Cancer Cell Motility and Metastasis Valbona Luga Doctor of Philosophy Department of Molecular Genetics University of Toronto 2013 Abstract The tumour-associated stroma, consisting of fibroblasts, inflammatory cells, vasculature and extracellular matrix proteins, plays a critical role in tumour growth, but how it regulates cancer cell migration and metastasis is poorly understood. The Wnt-planar cell polarity (PCP) pathway regulates convergent extension movements in vertebrate development. However, it is unclear whether this pathway also functions in cancer cell migration. In addition, the factors that mobilize long-range signalling of Wnt morphogens, which are tightly associated with the plasma membrane, have yet to be completely characterized. Here, I show that fibroblasts secrete membrane microvesicles of endocytic origin, termed exosomes, which promote tumour cell protrusive activity, motility and metastasis via the exosome component Cd81. In addition, I demonstrate that fibroblast exosomes activate autocrine Wnt-PCP signalling in breast cancer cells as detected by the association of Wnt with Fzd receptors and the asymmetric distribution of Fzd-Dvl and Vangl-Pk complexes in exosome-stimulated cancer cell protrusive structures. Moreover, I show that Pk expression in breast cancer cells is essential for fibroblast-stimulated cancer cell metastasis. Lastly, I reveal that trafficking in cancer cells promotes tethering of autocrine Wnt11 to fibroblast exosomes. These studies further our understanding of the role of ii the tumour-associated stroma in cancer metastasis and bring us closer to a more targeted approach for the treatment of cancer spread. -
Downloaded from Ftp://Ftp.Uniprot.Org/ on July 3, 2019) Using Maxquant (V1.6.10.43) Search Algorithm
bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. The proteomic landscape of resting and activated CD4+ T cells reveal insights into cell differentiation and function Yashwanth Subbannayya1, Markus Haug1, Sneha M. Pinto1, Varshasnata Mohanty2, Hany Zakaria Meås1, Trude Helen Flo1, T.S. Keshava Prasad2 and Richard K. Kandasamy1,* 1Centre of Molecular Inflammation Research (CEMIR), and Department of Clinical and Molecular Medicine (IKOM), Norwegian University of Science and Technology, N-7491 Trondheim, Norway 2Center for Systems Biology and Molecular Medicine, Yenepoya (Deemed to be University), Mangalore, India *Correspondence to: Professor Richard Kumaran Kandasamy Norwegian University of Science and Technology (NTNU) Centre of Molecular Inflammation Research (CEMIR) PO Box 8905 MTFS Trondheim 7491 Norway E-mail: [email protected] (Kandasamy R K) Tel.: +47-7282-4511 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.11.17.385096; this version posted November 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Abstract CD4+ T cells (T helper cells) are cytokine-producing adaptive immune cells that activate or regulate the responses of various immune cells. -
Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases That Correlates with Prolonged Survival
Published OnlineFirst January 17, 2020; DOI: 10.1158/1078-0432.CCR-19-2184 CLINICAL CANCER RESEARCH | TRANSLATIONAL CANCER MECHANISMS AND THERAPY Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival Kolja Pocha1, Andreas Mock1,2,3,4, Carmen Rapp1, Steffen Dettling1, Rolf Warta1,4, Christoph Geisenberger1, Christine Jungk1, Leila R. Martins5, Niels Grabe6, David Reuss7,8, Juergen Debus4,9, Andreas von Deimling4,7,8, Amir Abdollahi4,9, Andreas Unterberg1, and Christel C. Herold-Mende1,4 ABSTRACT ◥ Purpose: To provide a better understanding of the interplay of three surfactant metabolism-related genes (SFTPA1, SFTPB, between the immune system and brain metastases to advance and NAPSA) was closely associated with TIL numbers. Their therapeutic options for this life-threatening disease. expression was not only prognostic in brain metastasis but also Experimental Design: Tumor-infiltrating lymphocytes (TIL) in primary lung adenocarcinoma. Correlation with scRNA-seq were quantified by semiautomated whole-slide analysis in data revealed that brain metastases with high expression of brain metastases from 81 lung adenocarcinomas. Multi-color surfactant genes might originate from tumor cells resembling staining enabled phenotyping of TILs (CD3, CD8, and FOXP3) alveolar type 2 cells. Methylome-based estimation of immune cell on a single-cell resolution. Molecular determinants of the fractions in primary lung adenocarcinoma confirmed a positive extent of TILs in brain metastases were analyzed by transcrip- association between lymphocyte infiltration and surfactant tomics in a subset of 63 patients. Findings in lung adenocarci- expression. Tumors with a high surfactant expression displayed noma brain metastases were related to published multi-omic atranscriptomicprofile of an inflammatory microenvironment. -
Molecular Data, Functional Studies of the SH3 Recognition Motif and Correlation Between Wild-Type MED25 and PMP22 RNA Levels in CMT1A Animal Models
Neurogenetics (2009) 10:275–287 DOI 10.1007/s10048-009-0183-3 ORIGINAL ARTICLE Identification of the variant Ala335Val of MED25 as responsible for CMT2B2: molecular data, functional studies of the SH3 recognition motif and correlation between wild-type MED25 and PMP22 RNA levels in CMT1A animal models Alejandro Leal & Kathrin Huehne & Finn Bauer & Heinrich Sticht & Philipp Berger & Ueli Suter & Bernal Morera & Gerardo Del Valle & James R. Lupski & Arif Ekici & Francesca Pasutto & Sabine Endele & Ramiro Barrantes & Corinna Berghoff & Martin Berghoff & Bernhard Neundörfer & Dieter Heuss & Thomas Dorn & Peter Young & Lisa Santolin & Thomas Uhlmann & Michael Meisterernst & Michael Sereda & Gerd Meyer zu Horste & Klaus-Armin Nave & André Reis & Bernd Rautenstrauss Received: 8 October 2008 /Accepted: 19 February 2009 /Published online: 17 March 2009 # Springer-Verlag 2009 Abstract Charcot-Marie-Tooth (CMT) disease is a clini- known as ARC92 and ACID1, is a subunit of the human cally and genetically heterogeneous disorder. All mendelian activator-recruited cofactor (ARC), a family of large patterns of inheritance have been described. We identified a transcriptional coactivator complexes related to the yeast homozygous p.A335V mutation in the MED25 gene in an Mediator. MED25 was identified by virtue of functional extended Costa Rican family with autosomal recessively association with the activator domains of multiple cellular inherited Charcot-Marie-Tooth neuropathy linked to the and viral transcriptional activators. Its exact physiological CMT2B2 locus in chromosome 19q13.3. MED25, also function in transcriptional regulation remains obscure. The : A. Leal : K. Huehne : A. Ekici : F. Pasutto : S. Endele : A. Reis : P. Berger U. Suter B. Rautenstrauss HPM-II E39, Institute of Cell Biology, ETH Hönggerberg, Institute of Human Genetics, Friedrich-Alexander University, Swiss Federal Institute of Technology (ETH), Schwabachanlage 10, 8093 Zürich, Switzerland 91054 Erlangen, Germany A. -
Study of Urine Extracellular Vesicles-Derived Protein Biomarkers for the Non-Invasive Monitoring of Kidney-Transplanted Patients
ADVERTIMENT. Lʼaccés als continguts dʼaquesta tesi queda condicionat a lʼacceptació de les condicions dʼús establertes per la següent llicència Creative Commons: http://cat.creativecommons.org/?page_id=184 ADVERTENCIA. El acceso a los contenidos de esta tesis queda condicionado a la aceptación de las condiciones de uso establecidas por la siguiente licencia Creative Commons: http://es.creativecommons.org/blog/licencias/ WARNING. The access to the contents of this doctoral thesis it is limited to the acceptance of the use conditions set by the following Creative Commons license: https://creativecommons.org/licenses/?lang=en Study of urine extracellular vesicles-derived protein biomarkers for the non-invasive monitoring of kidney- transplanted patients Laura Carreras Planella Doctoral thesis Badalona, 20th October 2020 Thesis directors: Francesc Enric Borràs Serres, PhD Maria Isabel Troya Saborido, PhD 2 PhD programme in Advanced Immunology Department of Cellular Biology, Physiology and Immunology Universitat Autònoma de Barcelona Study of urine extracellular vesicles-derived protein biomarkers for the non-invasive monitoring of kidney-transplanted patients Estudi de biomarcadors proteics derivats de vesícules extracel·lulars de la orina per la monitorització no invasiva de pacients trasplantats de ronyó Thesis presented by Laura Carreras Planella to qualify for the PhD degree in Advanced Immunology by the Universitat Autònoma de Barcelona The presented work has been performed in the ReMAR-IVECAT group at the Germans Trias i Pujol Health Sciences Research Institute (IGTP) under the supervision of Dr. Francesc Enric Borràs Serres, as tutor and co-director, and Dr. Maria Isabel Troya Saborido as co-director. 3 Laura Carreras was sponsored by the Spanish Government with an FPU grant (“Formación de Personal Universitario”, FPU17/01444) and by La Fundació Cellex during the development of the PhD project. -
The Cancer Genome Atlas Dataset-Based Analysis of Aberrantly Expressed Genes by Geneanalytics in Thymoma Associated Myasthenia Gravis: Focusing on T Cells
2323 Original Article The Cancer Genome Atlas dataset-based analysis of aberrantly expressed genes by GeneAnalytics in thymoma associated myasthenia gravis: focusing on T cells Jianying Xi1#, Liang Wang1#, Chong Yan1, Jie Song1, Yang Song2, Ji Chen2, Yongjun Zhu2, Zhiming Chen2, Chun Jin3, Jianyong Ding3, Chongbo Zhao1,4 1Department of Neurology, 2Department of Thoracic Surgery, Huashan Hospital, Fudan University, Shanghai 200040, China; 3Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai 200030, China; 4Department of Neurology, Jing’an District Centre Hospital of Shanghai, Fudan University, Shanghai 200040, China Contributions: (I) Conception and design: J Xi, L Wang, C Zhao; (II) Administrative support: J Xi, L Wang, C Zhao; (III) Provision of study materials or patients: Y Song, Y Zhu, J Chen, Z Chen, C Jin, J Ding; (IV) Collection and assembly of data: C Jin, J Ding; (V) Data analysis and interpretation: C Yan, J Song; (VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors. #These authors contributed equally to this work. Correspondence to: Chongbo Zhao. Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China. Email: [email protected]. Background: Myasthenia gravis (MG) is a group of autoimmune disease which could be accompanied by thymoma. Many differences have been observed between thymoma-associated MG (TAMG) and non-MG thymoma (NMG). However, the molecular difference between them remained unknown. This study aimed to explore the differentially expressed genes (DEGs) between the two categories and to elucidate the possible pathogenesis of TAMG further. Methods: DEGs were calculated using the RNA-Sequencing data from 11 TAMG and 10 NMG in The Cancer Genome Atlas (TCGA) database. -
Molecular Subtypes of Diffuse Large B-Cell Lymphoma Arise by Distinct Genetic Pathways
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways Georg Lenza, George W. Wrightb, N. C. Tolga Emrea, Holger Kohlhammera, Sandeep S. Davea, R. Eric Davisa, Shannon Cartya, Lloyd T. Lama, A. L. Shaffera, Wenming Xiaoc, John Powellc, Andreas Rosenwaldd, German Ottd,e, Hans Konrad Muller-Hermelinkd, Randy D. Gascoynef, Joseph M. Connorsf, Elias Campog, Elaine S. Jaffeh, Jan Delabiei, Erlend B. Smelandj,k, Lisa M. Rimszal, Richard I. Fisherm,n, Dennis D. Weisenburgero, Wing C. Chano, and Louis M. Staudta,q aMetabolism Branch, bBiometric Research Branch, cCenter for Information Technology, and hLaboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892; dDepartment of Pathology, University of Wu¨rzburg, 97080 Wu¨rzburg, Germany; eDepartment of Clinical Pathology, Robert-Bosch-Krankenhaus, 70376 Stuttgart, Germany; fBritish Columbia Cancer Agency, Vancouver, British Columbia, Canada V5Z 4E6; gHospital Clinic, University of Barcelona, 08036 Barcelona, Spain; iPathology Clinic and jInstitute for Cancer Research, Rikshospitalet Hospital, Oslo, Norway; kCentre for Cancer Biomedicine, Faculty Division the Norwegian Radium Hospital, N-0310, Oslo, Norway; lDepartment of Pathology, University of Arizona, Tucson, AZ 85724; mSouthwest Oncology Group, 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48106 ; nJames P. Wilmot Cancer Center, University of Rochester, Rochester, NY 14642; and oDepartments of Pathology and Microbiology, University of Nebraska, Omaha, NE 68198 Edited by Ira -
Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases That Correlates with Prolonged Survival Authors
Author Manuscript Published OnlineFirst on January 17, 2020; DOI: 10.1158/1078-0432.CCR-19-2184 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Title Surfactant expression defines an inflamed subtype of lung adenocarcinoma brain metastases that correlates with prolonged survival Authors Kolja Pocha1*, Andreas Mock1,2,3,4*, Carmen Rapp1, Steffen Dettling1, Rolf Warta1,4, Christoph Geisenberger1, Christine Jungk1, Leila Martins5, Niels Grabe6, David Reuss7,8, Juergen Debus4,9, Andreas von Deimling4,7,8, Amir Abdollahi4,9, Andreas Unterberg1, Christel Herold-Mende1,4 Affiliations 1 Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University Hospital, Heidelberg, Germany 2 Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg University Hospital, Heidelberg, Germany 3 Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, German Cancer Research Center (DKFZ), Heidelberg, Germany 4 German Cancer Consortium (DKTK), Heidelberg, Germany 5 Division of Applied Functional Genomics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany 6 Hamamatsu Tissue Imaging and Analysis Center (TIGA), BIOQUANT, University of Heidelberg, Heidelberg, Germany 7 Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany 8 Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Institute of Pathology, Heidelberg -
An Integrative Multiomics Analysis Identifies Putative Causal Genes For
www.nature.com/gim ARTICLE An integrative multiomics analysis identifies putative causal genes for COVID-19 severity ✉ ✉ Lang Wu1,7 , Jingjing Zhu1,7, Duo Liu1,2, Yanfa Sun1,3,4,5 and Chong Wu6 PURPOSE: It is critical to identify putative causal targets for SARS coronavirus 2, which may guide drug repurposing options to reduce the public health burden of COVID-19. METHODS: We applied complementary methods and multiphased design to pinpoint the most likely causal genes for COVID-19 severity. First, we applied cross-methylome omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and 1,877,672 population controls. Second, we evaluated associations using the complementary S-PrediXcan method and leveraging blood and lung tissue gene expression prediction models. Third, we assessed associations of the identified genes with another COVID-19 phenotype, comparing very severe respiratory confirmed COVID versus population controls. Finally, we applied a fine-mapping method, fine-mapping of gene sets (FOGS), to prioritize putative causal genes. RESULTS: Through analyses of the COVID-19 HGI using complementary CMO and S-PrediXcan methods along with fine-mapping, XCR1, CCR2, SACM1L, OAS3, NSF, WNT3, NAPSA, and IFNAR2 are identified as putative causal genes for COVID-19 severity. CONCLUSION: We identified eight genes at five genomic loci as putative causal genes for COVID-19 severity. Genetics in Medicine; https://doi.org/10.1038/s41436-021-01243-5 1234567890():,; INTRODUCTION methods, and further apply the gene expression prediction The coronavirus disease 2019 (COVID-19) pandemic represents a models to genome-wide association study (GWAS) data sets of huge public health burden globally. -
Transcriptome Profiling of NIH3T3 Cell Lines Expressing Opsin and The
Pharmacological Research 115 (2017) 1–13 Contents lists available at ScienceDirect Pharmacological Research j ournal homepage: www.elsevier.com/locate/yphrs Transcriptome profiling of NIH3T3 cell lines expressing opsin and the P23H opsin mutant identifies candidate drugs for the treatment of retinitis pigmentosa a b b b Yuanyuan Chen , Matthew J. Brooks , Linn Gieser , Anand Swaroop , a,∗ Krzysztof Palczewski a Department of Pharmacology, Cleveland Center for Membrane and Structural Biology, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, United States b Neurobiology-Neurodegeneration & Repair Laboratory (N-NRL), National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda, MD 20892, United States a r a t i c l e i n f o b s t r a c t Article history: Mammalian cells are commonly employed in screening assays to identify active compounds that could Received 20 September 2016 potentially affect the progression of different human diseases including retinitis pigmentosa (RP), a class Received in revised form 18 October 2016 of inherited diseases causing retinal degeneration with compromised vision. Using transcriptome analy- Accepted 26 October 2016 sis, we compared NIH3T3 cells expressing wildtype (WT) rod opsin with a retinal disease-causing single Available online 9 November 2016 P23H mutation. Surprisingly, heterologous expression of WT opsin in NIH3T3 cells caused more than a 2-fold change in 783 out of 16,888 protein coding transcripts. The perturbed genes encoded extracellu- Keywords: lar matrix proteins, growth factors, cytoskeleton proteins, glycoproteins and metalloproteases involved Rhodopsin in cell adhesion, morphology and migration. A different set of 347 transcripts was either up- or down- P23H opsin regulated when the P23H mutant opsin was expressed suggesting an altered molecular perturbation Retinitis pigmentosa Transcriptome compared to WT opsin. -
Integrative Analysis of Multi-Omics Data Reveals Distinct Impacts Of
www.nature.com/scientificreports OPEN Integrative analysis of multi-omics data reveals distinct impacts of DDB1-CUL4 associated factors in Received: 27 September 2016 Accepted: 28 February 2017 human lung adenocarcinomas Published: xx xx xxxx Hong Yan1,2, Lei Bi2,3, Yunshan Wang2,4, Xia Zhang5, Zhibo Hou6, Qian Wang1, Antoine M. Snijders2 & Jian-Hua Mao2 Many DDB1-CUL4 associated factors (DCAFs) have been identified and serve as substrate receptors. Although the oncogenic role of CUL4A has been well established, specific DCAFs involved in cancer development remain largely unknown. Here we infer the potential impact of 19 well-defined DCAFs in human lung adenocarcinomas (LuADCs) using integrative omics analyses, and discover that mRNA levels of DTL, DCAF4, 12 and 13 are consistently elevated whereas VBRBP is reduced in LuADCs compared to normal lung tissues. The transcriptional levels of DCAFs are significantly correlated with their gene copy number variations. SKIP2, DTL, DCAF6, 7, 8, 13 and 17 are frequently gained whereas VPRBP, PHIP, DCAF10, 12 and 15 are frequently lost. We find that only transcriptional level of DTL is robustly, significantly and negatively correlated with overall survival across independent datasets. Moreover, DTL-correlated genes are enriched in cell cycle and DNA repair pathways. We also identified that the levels of 25 proteins were significantly associated with DTL overexpression in LuADCs, which include significant decreases in protein level of the tumor supressor genes such as PDCD4, NKX2-1 and PRKAA1. Our results suggest that different CUL4-DCAF axis plays the distinct roles in LuADC development with possible relevance for therapeutic target development.